Cigarette smoking and KRAS oncogene mutations in sporadic colorectal cancer: Results from the Netherlands Cohort Study

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 652, Issue 1, 2008, Pages 54-64

  Weijenberg, M P ^a   Aardening, P W M ^a   de Kok, T M ^a   de Goeij, A F P M ^a   van den Brandt, P A ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Colorectal cancer; KRAS oncogene; Molecular epidemiology; Netherlands Cohort Study; Prospective study; Smoking

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; RETINOL;

ADULT; AGED; ARTICLE; CALORIC INTAKE; CANCER RISK; CARCINOGENESIS; CIGARETTE SMOKING; COLORECTAL CANCER; CONTROLLED STUDY; FAT INTAKE; FEMALE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; NETHERLANDS; ONCOGENE K RAS; PHYSICAL ACTIVITY; POINT MUTATION; PRIORITY JOURNAL; SMOKING CESSATION; SMOKING HABIT; VITAMIN SUPPLEMENTATION;

ADENOCARCINOMA; AGED; ALCOHOL DRINKING; COHORT STUDIES; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GENES, RAS; HUMANS; INHALATION EXPOSURE; LINKAGE (GENETICS); MALE; MIDDLE AGED; POINT MUTATION; PROSPECTIVE STUDIES; RISK FACTORS; SEX CHARACTERISTICS; SMOKING; SMOKING CESSATION; TIME FACTORS;

EID: 40849151848     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2007.12.008     Document Type: Article

References (29)

1. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans (Vol. 83), Tobacco smoke and involuntary smoking, WHO-International Agency for Research on Cancer, Lyon, 2004.
2. Sasco A.J., Secretan M.B., and Straif K. Tobacco smoking and cancer: a brief review of recent epidemiological evidence. Lung Cancer 45 Suppl. 2 (2004) S3-S9
3. Giovannucci E. An updated review of the epidemiological evidence that cigarette smoking increases risk of colorectal cancer. Cancer Epidemiol. Biomarkers Prev. 10 (2001) 725-731
4. Ji B.T., Weissfeld J.L., Chow W.H., Huang W.Y., Schoen R.E., and Hayes R.B. Tobacco smoking and colorectal hyperplastic and adenomatous polyps. Cancer Epidemiol. Biomarkers Prev. 15 (2006) 897-901
5. Fearon E.R., and Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 61 (1990) 759-767
6. Kinzler K.W., and Vogelstein B. Lessons from hereditary colorectal cancer. Cell 87 (1996) 159-170
7. Bos J.L., Fearon E.R., Hamilton S.R., Verlaan-de Vries M., van Boom J.H., van der Eb A.J., and Vogelstein B. Prevalence of ras gene mutations in human colorectal cancers. Nature 327 (1987) 293-297
8. Vogelstein B., Fearon E.R., Hamilton S.R., Kern S.E., Preisinger A.C., Leppert M., Nakamura Y., White R., Smits A.M., and Bos J.L. Genetic alterations during colorectal-tumor development. N Engl. J. Med. 319 (1988) 525-532
9. Breivik J., Meling G.I., Spurkland A., Rognum T.O., and Gaudernack G. K-ras mutation in colorectal cancer: relations to patient age, sex and tumour location. Br. J. Cancer 69 (1994) 367-371
10. Brink M., de Goeij A.F., Weijenberg M.P., Roemen G.M., Lentjes M.H., Pachen M.M., Smits K.M., de Bruine A.P., Goldbohm R.A., and van den Brandt P.A. K-ras oncogene mutations in sporadic colorectal cancer in The Netherlands Cohort Study. Carcinogenesis 24 (2003) 703-710
11. Harris C.C. Chemical and physical carcinogenesis: advances and perspectives for the 1990s. Cancer Res. 51 (1991) 5023s-5044s
12. van den Brandt P.A., Goldbohm R.A., van 't Veer P., Volovics A., Hermus R.J., and Sturmans F. A large-scale prospective cohort study on diet and cancer in The Netherlands. J. Clin. Epidemiol. 43 (1990) 285-295
13. Van den Brandt P.A., Schouten L.J., Goldbohm R.A., Dorant E., and Hunen P.M. Development of a record linkage protocol for use in the Dutch cancer registry for epidemiological research. Int. J. Epidemiol. 19 (1990) 553-558
14. Barlow W.E., Ichikawa L., Rosner D., and Izumi S. Analysis of case-cohort designs. J. Clin. Epidemiol. 52 (1999) 1165-1172
15. Volovics A., and Van Den Brandt P.A. Methods for the analyses of case-cohort studies. Biom. J. 39 (1997) 159-214
16. Goldbohm R.A., van den Brandt P.A., Brants H.A., van't Veer P., Al M., Sturmans F., and Hermus R.J. Validation of a dietary questionnaire used in a large-scale prospective cohort study on diet and cancer. Eur. J. Clin. Nutr. 48 (1994) 253-265
17. Lin D.Y., and Wei L.J. The robust inference for the Cox Proportional Hazards Model. JASA 84 (1989) 1074-1078
18. Schoenfeld D. Partial residuals for the proportional hazards regression models. Biometrika 69 (1982) 239-241
19. Slattery M.L., Anderson K., Curtin K., Ma K., Schaffer D., Edwards S., and Samowitz W. Lifestyle factors and Ki-ras mutations in colon cancer tumors. Mutat. Res. 483 (2001) 73-81
20. Diergaarde B., Vrieling A., van Kraats A.A., van Muijen G.N., Kok F.J., and Kampman E. Cigarette smoking and genetic alterations in sporadic colon carcinomas. Carcinogenesis 24 (2003) 565-571
21. Wark P.A., Van der Kuil W., Ploemacher J., Van Muijen G.N., Mulder C.J., Weijenberg M.P., Kok F.J., and Kampman E. Diet, lifestyle and risk of K-ras mutation-positive and -negative colorectal adenomas. Int. J. Cancer 119 (2006) 398-405
22. Martinez M.E., Maltzman T., Marshall J.R., Einspahr J., Reid M.E., Sampliner R., Ahnen D.J., Hamilton S.R., and Alberts D.S. Risk factors for Ki-ras protooncogene mutation in sporadic colorectal adenomas. Cancer Res. 59 (1999) 5181-5185
23. Giovannucci E., Rimm E.B., Stampfer M.J., Colditz G.A., Ascherio A., Kearney J., and Willett W.C. A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. men. J. Natl. Cancer Inst. 86 (1994) 183-191
24. Giovannucci E., Colditz G.A., Stampfer M.J., Hunter D., Rosner B.A., Willett W.C., and Speizer F.E. A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. women. J. Natl. Cancer Inst. 86 (1994) 192-199
25. Luchtenborg M., Weijenberg M.P., Kampman E., van Muijen G.N., Roemen G.M., Zeegers M.P., Goldbohm R.A., van 't Veer P., de Goeij A.F., and van den Brandt P.A. Cigarette smoking and colorectal cancer: APC mutations, hMLH1 expression, and GSTM1 and GSTT1 polymorphisms. Am. J. Epidemiol. 161 (2005) 806-815
26. Yang P., Cunningham J.M., Halling K.C., Lesnick T.G., Burgart L.J., Wiegert E.M., Christensen E.R., Lindor N.M., Katzmann J.A., and Thibodeau S.N. Higher risk of mismatch repair-deficient colorectal cancer in alpha(1)-antitrypsin deficiency carriers and cigarette smokers. Mol. Genet. Metab. 71 (2000) 639-645
27. Wu A.H., Shibata D., Yu M.C., Lai M.Y., and Ross R.K. Dietary heterocyclic amines and microsatellite instability in colon adenocarcinomas. Carcinogenesis 22 (2001) 1681-1684
28. Samowitz W.S., Albertsen H., Sweeney C., Herrick J., Caan B.J., Anderson K.E., Wolff R.K., and Slattery M.L. Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer. J. Natl. Cancer Inst. 98 (2006) 1731-1738
29. Tanaka H., Deng G., Matsuzaki K., Kakar S., Kim G.E., Miura S., Sleisenger M.H., and Kim Y.S. BRAF mutation, CpG island methylator phenotype and microsatellite instability occur more frequently and concordantly in mucinous than non-mucinous colorectal cancer. Int. J. Cancer 118 (2006) 2765-2771